You can read it yourself, if you like. It’s in the Cambridge Coronavirus Collection.
Sørensen, Susrud & Dalgleish (2020) – Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity
Bear in mind the authors may have an economic interest: they’re developing a rival vaccine with an approach based on targeting “inserted sections” of the genome.